Fig. 4From: Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trialsEffect of aspirin on adverse events in people with diabetes. CI, confidence interval (bars); GI, gastro-intestinal; RR, relative risk; VTE, venous thromboembolismBack to article page